Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by canadafanon Oct 15, 2024 6:05pm
273 Views
Post# 36267186

Bought some more today

Bought some more today

I bought some more today. Not large amounts, as I already have plenty.
Just clearing out some loose $$ in our stock  accounts from various dividends.
just a few hundes shares , here & there.
Why buy more?
im certainly not selling, at these prices. 
I belive fully in the potential of the discussed enabling studies & accelerated approval.
The recent dips, imho provide great opportunities to average down.
being that I'm in until a buyout or partnership, might as well, support my investment.
They are in a " clinically " advantageous position right now. The $$ will come through if/ when they get further progress with approval.
read the online investor updates.
they need a parnership or similar to bring the MBc trial forward.
that is made very clear in the presentations.
when that happens the recent tiny price swings will show the insignificance of any Shareprice.
recall, a buyout if $1 billion + has been discussed.
some say wonderful, some say way too low.
As has been discovered , many recent buyouts have been much higher, for companies offering much less.

 

<< Previous
Bullboard Posts
Next >>